Tolerability and antitumor activity of cemiplimab, a human monoclonal anti–PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohort

Victor Moreno, Pilar Garrido, Kyriakos P. Papadopoulos, Maria Jose De Miguel Luken, Marta Gil-Martin, Raid Aljumaily, Lee S. Rosen, Petra Rietschel, Kosalai K. Mohan, Suk Young Yoo, Elizabeth Stankevich, Israel Lowy, Matthew G. Fury

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Tolerability and antitumor activity of cemiplimab, a human monoclonal anti–PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences